We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$9.85B
AUM Growth
+$544M
Cap. Flow
+$305M
Cap. Flow %
3.1%
Top 10 Hldgs %
10.6%
Holding
1,507
New
131
Increased
296
Reduced
233
Closed
100

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$70.2M
2
SRE icon
Sempra
SRE
+$62.5M
3
LNC icon
Lincoln National
LNC
+$62.2M
4
XL
XL Group Ltd.
XL
+$60.6M
5
NEE icon
NextEra Energy
NEE
+$58.5M

Sector Composition

Rank Sector Weight
1 Financials 23.55%
2 Industrials 12.89%
3 Consumer Discretionary 12.47%
4 Healthcare 10.29%
5 Technology 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOC icon
1301
Northrop Grumman
NOC
$77.1B
$215K ﹤0.01%
700
ATI icon
1302
ATI
ATI
$25.6B
$214K ﹤0.01%
8,500
NM
1303
DELISTED
Navios Maritime Holdings Inc.
NM
$213K ﹤0.01%
25,000
-17,000
-40% -$138K
EYPT icon
1304
EyePoint Inc
EYPT
$1.03B
$212K ﹤0.01%
10,190
MNI
1305
DELISTED
The McClatchy Company Class A Common Stock
MNI
$206K ﹤0.01%
20,681
-30,864
-60% -$301K
BBOX
1306
DELISTED
Black Box Corp
BBOX
$204K ﹤0.01%
100,594
-45,526
-31% -$99.8K
BKNG icon
1307
Booking.com
BKNG
$149B
$203K ﹤0.01%
2,500
BSQR
1308
DELISTED
BSQUARE Corporation
BSQR
$201K ﹤0.01%
74,500
+30,000
+67% +$112K
FCEL icon
1309
FuelCell Energy
FCEL
$1.73B
$198K ﹤0.01%
+416
New +$273K
CSLT
1310
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$193K ﹤0.01%
45,500
UG icon
1311
United-Guardian
UG
$32.4M
$192K ﹤0.01%
10,000
AAME icon
1312
Atlantic American Corp
AAME
$31.4M
$191K ﹤0.01%
74,856
KND
1313
DELISTED
Kindred Healthcare
KND
$189K ﹤0.01%
21,000
-494,750
-96% -$4.43M
BDR
1314
DELISTED
Blonder Tongue Laboratories Inc
BDR
$178K ﹤0.01%
+157,500
New +$168K
ARL icon
1315
American Realty Investors
ARL
$246M
$175K ﹤0.01%
+11,100
New +$185K
SSKN
1316
DELISTED
Strata Skin Sciences
SSKN
$174K ﹤0.01%
8,500
RMTI icon
1317
Rockwell Medical
RMTI
$28.4M
$173K ﹤0.01%
318
SMIT
1318
DELISTED
Schmitt Industries Inc
SMIT
$173K ﹤0.01%
70,802
LIVE icon
1319
Live Ventures
LIVE
$29.8M
$172K ﹤0.01%
13,702
ARAV
1320
DELISTED
Aravive, Inc. Common Stock
ARAV
$172K ﹤0.01%
14,183
-5,063
-26% -$52.1K
HTGM
1321
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$171K ﹤0.01%
292
PKD
1322
DELISTED
Parker Drilling Company
PKD
$168K ﹤0.01%
29,389
-24,560
-46% -$187K
ALJJ
1323
DELISTED
ALJ Regional Holdings Inc
ALJJ
$167K ﹤0.01%
88,000
KSPN
1324
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$166K ﹤0.01%
9,523
-507
-5% -$11.8K
DDE
1325
DELISTED
Dover Downs Gaming & Entertain
DDE
$166K ﹤0.01%
93,334

Similar funds

Bridgeway Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Bridgeway Capital Management held 1,507 positions worth $9.85B, up 5.8% from $9.31B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Bridgeway Capital Management deployed $305M of net new capital in Q2 2018, opening 131 new positions and adding to 296 existing holdings. Its largest new stake was Morgan Stanley: 1,333,400 shares worth $63.2M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Lam Research, an estimated $70.2M trimmed.

  • Bridgeway Capital Management's largest Q2 2018 buy was Morgan Stanley: 1,333,400 shares worth $63.2M.
  • Bridgeway Capital Management added most to Cigna in Q2 2018, an estimated $58.3M increase.
  • Bridgeway Capital Management's biggest Q2 2018 reduction was Lam Research, cutting an estimated $70.2M.
  • Bridgeway Capital Management fully exited Sempra in Q2 2018, selling an estimated $62.5M.
  • Bridgeway Capital Management's ten largest holdings make up 11% of its $9.85B portfolio in Q2 2018.
  • Bridgeway Capital Management opened 131 new positions and closed 100 in Q2 2018.
  • Bridgeway Capital Management's portfolio value rose 5.8% quarter-over-quarter to $9.85B.

Based on Bridgeway Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.